American Portfolios Advisors Can Fite Bio Pharma Ltd. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Can Fite Bio Pharma Ltd. stock. As of the latest transaction made, American Portfolios Advisors holds 1,100 shares of CANF stock, worth $2,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,100
Holding current value
$2,210
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$0.74 - $7.9 $814 - $8,690
1,100 New
1,100 $847,000

Others Institutions Holding CANF

# of Institutions
2
Shares Held
1.1K
Call Options Held
0
Put Options Held
0
View Full List

About Can-Fite BioPharma Ltd.

CANF Quotes by TradingView
  • Ticker CANF
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,191,500
  • Market Cap $54.7M
  • Description
  • Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...
More about CANF
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email